The landscape of immune checkpoint inhibitor plus chemotherapy versus immunotherapy for advanced non‐small‐cell lung cancer: A systematic review and meta‐analysis

BACKGROUND: Lung cancer is the leading cause of cancer‐related deaths worldwide and the prognosis remains poor. The recent introduction of the immune checkpoint inhibitor (ICI), or plus chemotherapy, both resulted in the survival benefit for patients with advanced non‐small‐cell lung cancer (NSCLC),...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Cell Physiol
Main Authors: Wang, Chengdi, Qiao, Wenliang, Jiang, Yuting, Zhu, Min, Shao, Jun, Wang, Tao, Liu, Dan, Li, Weimin
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2019
Fag:
Original Research Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7028135/
https://ncbi.nlm.nih.gov/pubmed/31693178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcp.29371
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker